No Record Found
Sector
PharmaceuticalsOpen
₹325.4Prev. Close
₹323.95Turnover(Lac.)
₹702.19Day's High
₹325.4Day's Low
₹31552 Week's High
₹33552 Week's Low
₹176.05Book Value
₹81.58Face Value
₹1Mkt Cap (₹ Cr.)
2,960.81P/E
37.42EPS
8.66Divi. Yield
0.129 Aug 2025
12:00 AM
AGM
Announcement Date: 09 Aug, 2025
30 May 2025
12:00 AM
Dividend
Dividend Amount: 0.4
Record Date: 22 Sep, 2025
3 Nov 2025
12:00 AM
Board Meeting
Agenda : Audited Result
9 Aug 2025
12:00 AM
BookCloser
SMS Pharma added that it will submit its formal response to the USFDA within the stipulated timeline, in line with standard regulatory practice.
For the June quarter, SMS Pharma reported a 24.3% year-on-year jump in net profit to ₹20.49 crore, compared with ₹16.48 crore a year earlier.
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 24.75 | 37.05 | 8.47 | 8.47 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 648.33 | 533.45 | 486.63 | 485.3 |
Net Worth | 673.08 | 570.5 | 495.1 | 493.77 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 563.17 | 411.94 | 462.67 | 438.12 |
yoy growth (%) | 36.71 | -10.96 | 5.6 | -27.36 |
Raw materials | -339.99 | -246.36 | -289.89 | -295.84 |
As % of sales | 60.37 | 59.8 | 62.65 | 67.52 |
Employee costs | -41.17 | -39.35 | -32.8 | -26.92 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 91.11 | 50.75 | 60.34 | 41.58 |
Depreciation | -22.28 | -22.06 | -19.89 | -19.17 |
Tax paid | -30.15 | -18.06 | -19.89 | -5.96 |
Working capital | 60.27 | 35.89 | 36.48 | -52.78 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 36.71 | -10.96 | 5.6 | -27.36 |
Op profit growth | 51.54 | -14.37 | 24.78 | -16.14 |
EBIT growth | 62.43 | -16.96 | 32.87 | -22.21 |
Net profit growth | 86.5 | -19.19 | 13.58 | -14.46 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 782.75 | 709.26 | 522.05 | 519.87 | 563.18 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 782.75 | 709.26 | 522.05 | 519.87 | 563.18 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 6.22 | 4.46 | 4.91 | 5.2 | 3.45 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,797.1 | 92.26 | 4,31,220.48 | 564.22 | 0.89 | 4,511.27 | 99.24 |
Divis Laboratories Ltd DIVISLAB | 6,347.5 | 67.02 | 1,68,486.27 | 696 | 0.47 | 2,660 | 578.26 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,782.6 | 59.96 | 1,27,957.09 | 597 | 0.16 | 2,707 | 249.83 |
Cipla Ltd CIPLA | 1,508 | 23.42 | 1,21,751.32 | 1,210.53 | 1.06 | 4,495.16 | 411.56 |
Dr Reddys Laboratories Ltd DRREDDY | 1,280.6 | 19.8 | 1,06,866.07 | 387.3 | 0.62 | 4,602.9 | 377.56 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
P Ramesh Babu
Independent Director
P Sarath Kumar
Independent Director
Thummala Neelaveni
Independent Director
Shravan Kudaravalli
Independent Director
Sarvepalli Srinivas
Executive Director
Vamsi Krishna Potluri
Company Sec. & Compli. Officer
Thirumalesh Tumma
Independent Director
Trilok Potluri.
Non Executive Director
Sunkara Venkata Satya Shiva Prasad
Independent Director
G Suresh Kumar
Independent Director
Shanti Sree Bolleni
19 III Rd 71 Opp Bharatividya,
Bhavan Public Sch Jubilee Hill,
Telangana - 500096
Tel: 91-40-66288888
Website: http://www.smspharma.com
Email: cs@smspharma.com; complianceofficer@smspharma.com;
1-2-285 Domalguda,
Hyderabad - 500 029
Tel: 91-040-27638111/4445
Website: www.aarthiconsultants.com
Email: info@aarthiconsultants.com
Summary
SMS Pharmaceuticals Limited was incorporated in December, 1987. The company is engaged in the business of manufacturing of Active Pharma Ingredients and their intermediates. Apart from R &D Center at ...
Read More
Reports by SMS Pharmaceuticals Ltd
What is the SMS Pharmaceuticals Ltd share price today?
What is the Market Cap of SMS Pharmaceuticals Ltd?
What is the PE and PB ratio of SMS Pharmaceuticals Ltd?
What is the 52 Week High and Low of SMS Pharmaceuticals Ltd?
What is the CAGR of SMS Pharmaceuticals Ltd?
What is the shareholding pattern of SMS Pharmaceuticals Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
